NantKwest
E932805
NantKwest is a biotechnology company focused on developing natural killer (NK) cell-based immunotherapies for cancer and other diseases.
All labels observed (1)
| Label | Occurrences |
|---|---|
| NantKwest canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T11553578 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: NantKwest Context triple: [Patrick Soon-Shiong, founded, NantKwest]
-
A.
Nesta
Nesta is the middle name of legendary Jamaican reggae musician and cultural icon Bob Marley.
-
B.
Tencteri
The Tencteri were an ancient Germanic tribe known from Roman sources for inhabiting the region along the lower Rhine and participating in conflicts with the Roman Empire.
-
C.
Naux
Naux was a guitarist known for his work with the influential New York punk band Richard Hell and the Voidoids.
-
D.
Nadsiannia
Nadsiannia is a historical and ethnographic region of Eastern Europe associated with Ukrainian highlander culture and situated near the Lemko region.
-
E.
Nesiota
Nesiota is a small, likely extinct genus of flowering plants in the buckthorn family Rhamnaceae, historically known from the South Atlantic island of St. Helena.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: NantKwest Target entity description: NantKwest is a biotechnology company focused on developing natural killer (NK) cell-based immunotherapies for cancer and other diseases.
-
A.
Nesta
Nesta is the middle name of legendary Jamaican reggae musician and cultural icon Bob Marley.
-
B.
Tencteri
The Tencteri were an ancient Germanic tribe known from Roman sources for inhabiting the region along the lower Rhine and participating in conflicts with the Roman Empire.
-
C.
Naux
Naux was a guitarist known for his work with the influential New York punk band Richard Hell and the Voidoids.
-
D.
Nadsiannia
Nadsiannia is a historical and ethnographic region of Eastern Europe associated with Ukrainian highlander culture and situated near the Lemko region.
-
E.
Nesiota
Nesiota is a small, likely extinct genus of flowering plants in the buckthorn family Rhamnaceae, historically known from the South Atlantic island of St. Helena.
- F. None of above. chosen
Statements (47)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology company
ⓘ
public company ⓘ |
| aimsTo |
treat cancer
ⓘ
treat infectious diseases ⓘ treat inflammatory diseases ⓘ |
| basedIn |
California, United States
ⓘ
surface form:
California
|
| boardMember | Patrick Soon-Shiong NERFINISHED ⓘ |
| chiefExecutiveOfficer | Patrick Soon-Shiong NERFINISHED ⓘ |
| collaboratesWith | ImmunityBio NERFINISHED ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| develops |
allogeneic NK cell therapies
ⓘ
off-the-shelf NK cell therapies ⓘ |
| focusesOn |
cancer immunotherapy
ⓘ
immunotherapies for infectious diseases ⓘ immunotherapies for inflammatory diseases ⓘ natural killer cell-based immunotherapies ⓘ |
| foundedBy | Patrick Soon-Shiong NERFINISHED ⓘ |
| founder | Patrick Soon-Shiong NERFINISHED ⓘ |
| hasAbbreviation | NK NERFINISHED ⓘ |
| hasApproach | allogeneic, off-the-shelf cell therapy ⓘ |
| hasBusinessModel | clinical-stage biopharmaceutical development ⓘ |
| hasKeyPerson | Patrick Soon-Shiong NERFINISHED ⓘ |
| hasPipeline | clinical-stage NK cell therapeutics ⓘ |
| hasResearchFocus |
antibody-dependent cellular cytotoxicity enhancement
ⓘ
combination immunotherapy ⓘ tumor-targeted NK cell therapy ⓘ |
| hasTechnologyPlatform |
activated natural killer cell platform
ⓘ
off-the-shelf NK cell platform ⓘ |
| headquartersLocation | San Diego, California NERFINISHED ⓘ |
| industry | biotechnology ⓘ |
| mergedInto | ImmunityBio NERFINISHED ⓘ |
| parentOrganization | ImmunityBio NERFINISHED ⓘ |
| partOf | NantWorks ecosystem NERFINISHED ⓘ |
| targetPatientGroup |
cancer patients
ⓘ
patients with infectious diseases ⓘ patients with inflammatory diseases ⓘ |
| therapeuticArea |
autoimmune diseases
ⓘ
infectious diseases ⓘ oncology ⓘ |
| tickerSymbol | NK NERFINISHED ⓘ |
| tradedOn | NASDAQ NERFINISHED ⓘ |
| usesCellType |
CD16 receptor-expressing NK cells
ⓘ
natural killer cells ⓘ |
| usesMechanismOfAction |
activation of natural killer cells
ⓘ
antibody-dependent cellular cytotoxicity ⓘ |
| usesModality |
cell therapy
ⓘ
immunotherapy ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: NantKwest Description of subject: NantKwest is a biotechnology company focused on developing natural killer (NK) cell-based immunotherapies for cancer and other diseases.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.